Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 29:9:870503.
doi: 10.3389/fmed.2022.870503. eCollection 2022.

Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report

Affiliations
Case Reports

Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report

Omar Ala' Alajjuri et al. Front Med (Lausanne). .

Abstract

Background: Bartter syndrome, a very rare inherited renal tubular disorder, characterized by urinary salt wastage, hypokalemia, polyuria, and metabolic alkalosis, may manifest antenatally as severe isolated polyhydramnios. Indomethacin is known to reduce salt wastage and subsequent polyhydramnios during pregnancy; however, it reduces the Ductus Arteriosus diameter among other potential complications, such as inhibition of gastrointestinal perfusion and increasing the risk of renal toxicity.

Case: A 36-year-old multigravida presented with severe isolated polyhydramnios at 30 weeks of gestation. Based on a history of a previous pregnancy affected with Bartter syndrome, indomethacin was initiated. Amniotic fluid volume and Ductus Arteriosus diameter were monitored. As evidence lacks on optimal dose and duration of indomethacin, multiple-dose adjustments were made to reduce the amniotic fluid volume while maintaining normal Ductus Arteriosus diameter. Progressive polyhydramnios led to Cesarean section at 34+ weeks of gestation resulting in a healthy fetus diagnosed with Bartter syndrome in the early neonatal period.

Conclusion: We share our experience in the adjustment of the dose and duration of Indomethacin therapy in the treatment of severe polyhydramnios associated with antenatal Bartter syndrome. Amniotic fluid index, Ductus Arteriosus diameter, and umbilical artery doppler work together as key indicators to guide the success and safety of the therapy.

Keywords: Bartter syndrome; Ductus Arteriosus; amniotic fluid index; indomethacin; polyhydramnios.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
An ultrasound scan showing severe polyhydramnios with a single DVP of 13.9 cm at 30 weeks and 2 days.
Figure 2
Figure 2
An ultrasound scan showing an AFI of 24.1 cm at 31 weeks 2 days.
Figure 3
Figure 3
An ultrasound scan shows DA diameter at 31 weeks 6 days (3.57 mm, 6th centile).
Figure 4
Figure 4
An ultrasound scan showing findings at 34 weeks + 2 days (A): AFI of 45.9 cm. (B): Umbilical artery Doppler waveform with increased PI above the 99th centile.
Figure 5
Figure 5
A summary diagram to outline changes in AFI and DA diameter during the antenatal indomethacin therapy of the patient.

Similar articles

Cited by

References

    1. Cunha TDS, Heilberg IP. Bartter syndrome: causes, diagnosis, and treatment. Int J Nephrol Renov Dis. (2018) 11:291–301. 10.2147/IJNRD.S155397 - DOI - PMC - PubMed
    1. Bhat YR, Vinayaka G, Sreelakshmi K. Antenatal bartter syndrome: a review. Int J Pediatr. (2012) 2012:857136. 10.1155/2012/857136 - DOI - PMC - PubMed
    1. Kömhoff M, Laghmani K. Pathophysiology of antenatal bartter's syndrome. Curr Opin Nephrol Hypert. (2017) 26:419–25. 10.1097/MNH.0000000000000346 - DOI - PubMed
    1. Bhat YR, Vinayaka G, Vani R, Prashanth KA, Sreelakshmi K. Antenatal bartter syndrome: a rare cause of unexplained severe polyhydramnios. Ann Trop Paediatr. (2011) 31:153–7. 10.1179/1465328111Y.0000000006 - DOI - PubMed
    1. Hallak M, Kirshon B, Smith EO, Cotton DB. Amniotic fluid index. Gestational age-specific values for normal human pregnancy. J Reproduct Med. (1993) 38:853–6. - PubMed

Publication types